LogicBio Therapeutics Inc
General ticker "LOGC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $161.5M (TTM average)
LogicBio Therapeutics Inc follows the US Stock Market performance with the rate: 50.1%.
Estimated limits based on current volatility of 2.5%: low 6.77$, high 7.13$
Short-term LOGC quotes
Long-term LOGC plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $571.00MM | $287.00MM | $43.00MM |
| Operating Expenses | $969.00MM | $615.00MM | $122.00MM |
| Operating Income | $-398.00MM | $-328.00MM | $-79.00MM |
| Non-Operating Income | $15.00MM | $16.00MM | $10.00MM |
| R&D Expense | $194.00MM | $152.00MM | $26.00MM |
| Income(Loss) | $-383.00MM | $-312.00MM | $-69.00MM |
| Taxes | $1.00MM | $5.00MM | $6.00MM |
| Profit(Loss)* | $-384.00MM | $-317.00MM | $-75.00MM |
| Stockholders Equity | $477.00MM | $217.00MM | $151.00MM |
| Assets | $799.00MM | $423.00MM | $156.00MM |
| Operating Cash Flow | $-422.00MM | $-341.00MM | $-94.00MM |
| Capital expenditure | $2.00MM | $3.00MM | $0.00MM |
| Investing Cash Flow | $-47.00MM | $74.00MM | $-68.00MM |
| Financing Cash Flow | $-22.00MM | $-5.00MM | $-1.00MM |
| Earnings Per Share** | $-17.13 | $-13.36 | $-2.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.